Streetbeat News

Stock Prices

XBIO

Xenetic Biosciences (NASDAQ: XBIO) reported Q2 EPS of $(0.83), missing the $(0.15) estimate by a significant margin. However, sales of $726.40K beat the $570.00K estimate.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:41 pm

INTU

Intuit shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $750 to $685.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:36 pm

DKNG

DraftKings shares are trading higher after the company announced it will not proceed with the gaming tax surcharge.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:36 pm

ANAB

ARM

ASML

CAH

FXY

IWM

K

MU

QQQ

SMH

SPY

VSCO

The July Consumer Price Index report showed a slight decline in inflation, fueling hopes for a Federal Reserve rate cut. This led to a positive reaction in the stock market, particularly in tech and small-cap stocks. Key ETFs and stocks saw notable premarket movements.

Portfolio Pulse from Piero Cingari

August 14, 2024 | 1:36 pm

REBN

Reborn Coffee Inc (NASDAQ:REBN) shares surged by 40% to $3.90 after announcing a Master License Agreement with Shenyang Yongsheng Seven Stars Tourism Development Co. to expand into China. The partnership will establish Reborn Coffee's presence in Shenyang, the capital of Liaoning Province, and aims for further expansion across the province.

Portfolio Pulse from Henry Khederian

August 14, 2024 | 1:34 pm

PFGC

Performance Good Group shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:33 pm

FNV

Franco-Nevada shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:32 pm

MNPR

Monopar Therapeutics shares are trading higher following the announcement that no serious adverse reactions were reported from the first patient initial data in its radiopharma Phase 1 clinical trial of MNPR-101-Zr.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:29 pm

CMG

SBUX

Chipotle Mexican Grill Inc (NYSE:CMG) shares are trading slightly higher after a 7.5% drop due to the departure of CEO Brian Niccol, who will join Starbucks Corp (NYSE:SBUX) as chairman and CEO. Chipotle appointed COO Scott Boatwright as Interim CEO and Jack Hartung as President of Strategy, Finance, and Supply Chain. Analysts have mixed reactions, with some maintaining or lowering price targets.

Portfolio Pulse from Adam Eckert

August 14, 2024 | 1:29 pm

GNPX

Genprex reports positive updates from its Acclaim-1 and Acclaim-3 Phase 1/2 clinical trials in lung cancer, showing prolonged progression-free survival and partial remission in patients. The company is refocusing its oncology clinical development program and advancing work on biomarkers to enrich clinical trial patient populations.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:28 pm